A flow-cytometric method to investigate glutamate-receptor-sensitivity in whole blood platelets - Results from healthy controls and patients with schizophrenia

被引:14
作者
Baier, Paul C. [1 ]
Koch, Jakob M. [1 ]
Seeck-Hirschner, Mareen [1 ]
Ohlmeyer, Kathrin [1 ]
Wilms, Sibylle [1 ]
Aldenhoff, Josef B. [1 ]
Hinze-Selch, Dunja [1 ]
机构
[1] Univ Kiel, Dept Psychiat & Psychotherapy, D-24105 Kiel, Germany
关键词
Blood platelets; Human; Schizophrenia; Metabotropic quisqualate receptor; N-Methyl-D-Aspartate (NMDA) receptor; Neuroleptic drugs; CALCIUM MOBILIZATION; PLASMA GLUTAMATE; RICH PLASMA; NMDA; MODEL; ACTIVATION; TRANSPORT; DOPAMINE; NEURON;
D O I
10.1016/j.jpsychires.2008.07.005
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Hypofunction of glutamate receptors may contribute to the symptoms of schizophrenia. Human platelets express glutamate receptors and can serve as peripheral surrogate model for neuronal cells. Aim of this study was to establish a fast and sensitive flow-cytometric method to determine the glutamate-dependent kinetics of intracellular calcium ([Ca++]i) mobilization in platelets of schizophrenic patients. Glutamate stimulated [Ca++]i response was measured with a flow-cytometer in anti-CD-41a-labelled whole blood platelets of treated schizophrenic patients (n = 18) and controls (n = 18). In two control experiments the NMDA-receptor antagonist MK-801 and the dopamine antagonist amisulpride, respectively, were added to probes from healthy subjects. Stimulation with glutamate led dose-dependently to a mobilization of [Ca++]i in both healthy controls and patients. This effect was significantly reduced in patients. In vitro NMDA-antagonism inhibited the glutamate response, whereas dopamine-antagonism had no effect. Our flow-cytometric method allows to measure glutamate-receptor mediated [Ca++]i response in whole blood platelets, without requiring platelet rich preparations. The reduced glutamate-response in the patients was not explained by a direct inhibitory treatment effect. However, further studies with drug naive patients will be necessary to find out whether or not the observed hypoglutamergic function of platelets is endogenous to the disorder. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:585 / 591
页数:7
相关论文
共 37 条
[11]   THE PLATELET POLYPHOSPHOINOSITIDE SYSTEM IN SCHIZOPHRENIA - THE EFFECTS OF NEUROLEPTIC TREATMENT [J].
ESSALI, MA ;
DAS, I ;
DEBELLEROCHE, J ;
HIRSCH, SR .
BIOLOGICAL PSYCHIATRY, 1990, 28 (06) :475-487
[12]   Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics [J].
Evins, AE ;
Amico, ET ;
Shih, V ;
Goff, DC .
JOURNAL OF NEURAL TRANSMISSION, 1997, 104 (6-7) :761-766
[13]   CATIONIC AND ANIONIC AMINO-ACID-TRANSPORT STUDIES IN RAT RED-BLOOD-CELLS [J].
FELIPE, A ;
VINAS, O ;
REMESAR, X .
BIOSCIENCE REPORTS, 1990, 10 (06) :527-535
[14]   PLATELET ACTIVATION DURING PREPARATION OF PLATELET CONCENTRATES - A COMPARISON OF THE PLATELET-RICH PLASMA AND THE BUFFY COAT METHODS [J].
FIJNHEER, R ;
PIETERSZ, RNI ;
DEKORTE, D ;
GOUWEROK, CWN ;
DEKKER, WJA ;
REESINK, HW ;
ROOS, D .
TRANSFUSION, 1990, 30 (07) :634-638
[15]   REGULATION OF CORTICAL AND SUBCORTICAL GLUTAMATE-RECEPTOR SUBUNIT EXPRESSION BY ANTIPSYCHOTIC-DRUGS [J].
FITZGERALD, LW ;
DEUTCH, AY ;
GASIC, G ;
HEINEMANN, SF ;
NESTLER, EJ .
JOURNAL OF NEUROSCIENCE, 1995, 15 (03) :2453-2461
[16]  
Franconi F, 1996, THROMB HAEMOSTASIS, V76, P84
[17]   Further insights into the anti-aggregating activity of NMDA in human platelets [J].
Franconi, F ;
Miceli, M ;
Alberti, L ;
Seghieri, G ;
De Montis, MG ;
Tagliamonte, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (01) :35-40
[18]   Dynamic regulation of glutamatergic postsynaptic activity in rat prefrontal cortex by repeated administration of antipsychotic drugs [J].
Fumagalli, Fabio ;
Frasca, Angelisa ;
Racagni, Giorgio ;
Riva, Marco Andrea .
MOLECULAR PHARMACOLOGY, 2008, 73 (05) :1484-1490
[19]   Platelet dopamine receptors and oxidative stress parameters as markers of manganese toxicity [J].
Husain, M ;
Khanna, VK ;
Roy, A ;
Tandon, R ;
Pradeep, S ;
Seth, PK .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2001, 20 (12) :631-636
[20]   Increased plasma glutamate by antipsychotic medication and its relationship to glutaminase 1 and 2 genotypes in schizophrenia - Juntendo University Schizophrenia Projects (JUSP) [J].
Maeshima, Hitoshi ;
Ohnuma, Tohru ;
Sakai, Yoshie ;
Shibata, Nobuto ;
Baba, Hajime ;
Ihara, Hiroshi ;
Higashi, Maiko ;
Ohkubo, Taku ;
Nozawa, Eiko ;
Abe, Sawako ;
Ichikawa, Aya ;
Nakano, Yoshiyuki ;
Utsumi, Yushi ;
Suzuki, Toshihito ;
Arai, Heii .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2007, 31 (07) :1410-1418